CRH 9 41

Drug Profile

CRH 9 41

Alternative Names: Alpha-helical-CRH 9 41; Corticotropin releasing hormone 9 41

Latest Information Update: 14 Nov 2003

Price : $50

At a glance

  • Originator Unknown
  • Class
  • Mechanism of Action Corticotropin-releasing factor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Infantile spasms

Most Recent Events

  • 14 Nov 2003 Discontinued - Phase-I for Infantile spasms in USA (IV)
  • 21 Jul 1999 No-Development-Reported for Infantile spasms in USA (IV)
  • 07 Apr 1997 Phase-I clinical trials for Infantile spasms in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top